Results 141 to 145 of about 818 (145)

A novel liposomal adjuvant system, CAF01, promotes long-lived -specific T-cell responses in human

Vaccine, 2014
Soren Tetens Hoff, Morten Ruhwald, Peter Andersen   +2 more
exaly  

Development and Evaluation of CAF01

2017
Dennis Christensen
exaly  

CAF01 liposomes as a mucosal vaccine adjuvant: and investigations

International Journal of Pharmaceutics, 2010
Peter Andersen, Hanne Mørck Nielsen, Ida Rosenkrands   +2 more
exaly  

A CAF01-adjuvanted whole asexual blood-stage liposomal malaria vaccine induces a CD4+ T-cell-dependent strain-transcending protective immunity in rodent models.

MBio
Michael F. Good, Danielle I Stanisic, Winter A Okoth   +2 more
exaly  

Safety and immunogenicity of GMZ2 adjuvanted with aluminum hydroxide and CAF01 in semi-immune Gabonese volunteers and the impact of helminth infection on vaccine immunogenicity

exaly